Analysis Of Income And Expense [Abstract]

Biotage - Filing #678905

Concept 2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
Analysis of income and expense [abstract]
Revenue [abstract]
Revenue
1 862 SEK
1 566 SEK
Material income and expense [abstract]
Research and development expense
159,000,000 SEK
109,000,000 SEK
Finance income (cost)
11,000,000 SEK
21,000,000 SEK
Selling, general and administrative expense [abstract]
Selling expense
457,000,000 SEK
3 79 SEK
Comprehensive income, continuing and discontinued operations [abstract]
Comprehensive income
SEK
SEK
91,000,000 SEK
2 46 SEK
155,000,000 SEK
SEK
352,000,000 SEK
268,000,000 SEK
84,000,000 SEK
SEK
Comprehensive income attributable to owners of parent, continuing and discontinued operations [abstract]
Comprehensive income, attributable to owners of parent
91,000,000 SEK
352,000,000 SEK

Talk to a Data Expert

Have a question? We'll get back to you promptly.